Elisa M. Rice

Array ( [id] => 20626714 [patent_doc_number] => 20260090996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-02 [patent_title] => DELAYED RELEASE ORAL PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 19/399068 [patent_app_country] => US [patent_app_date] => 2025-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4179 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19399068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20626731 [patent_doc_number] => 20260091013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-02 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 19/352061 [patent_app_country] => US [patent_app_date] => 2025-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 100278 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19352061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20083536 [patent_doc_number] => 20250213472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => IMMUNOMODULATORY HYDROGEL AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 19/004480 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19004480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19854415 [patent_doc_number] => 12257223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 18/889070 [patent_app_country] => US [patent_app_date] => 2024-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 112510 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18889070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691160 [patent_doc_number] => 20250009705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 18/889055 [patent_app_country] => US [patent_app_date] => 2024-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18889055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19808266 [patent_doc_number] => 12239625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 18/889023 [patent_app_country] => US [patent_app_date] => 2024-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 146 [patent_no_of_words] => 112511 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18889023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554756 [patent_doc_number] => 20240366548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 18/760757 [patent_app_country] => US [patent_app_date] => 2024-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18760757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554755 [patent_doc_number] => 20240366547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 18/759364 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112623 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18759364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19570257 [patent_doc_number] => 20240374549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 18/758699 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18758699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19541631 [patent_doc_number] => 20240358667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 18/759320 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18759320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19541630 [patent_doc_number] => 20240358666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 18/758081 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 103417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18758081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19535488 [patent_doc_number] => 12128021 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-10-29 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 18/643773 [patent_app_country] => US [patent_app_date] => 2024-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 112420 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18643773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19526510 [patent_doc_number] => 20240350412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => METHOD OF PREPARING POUCH FILLING MATERIAL USING BINDER [patent_app_type] => utility [patent_app_number] => 18/640463 [patent_app_country] => US [patent_app_date] => 2024-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359192 [patent_doc_number] => 20240261226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => Medicinal and Edible Dual-Purpose Composition Capable of Resisting Retinal Blue Light Damage, and Preparation Method and Application Thereof [patent_app_type] => utility [patent_app_number] => 18/622350 [patent_app_country] => US [patent_app_date] => 2024-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18622350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462545 [patent_doc_number] => 20240316214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => PREPARATION METHOD AND APPLICATION OF A TARGETED PEPTIDE MODIFIED NANODRUG DELIVERY SYSTEM (PDC) WITH SPECIFIC BINDING TO THE NEUROTENSIN RECEPTOR (NTR) [patent_app_type] => utility [patent_app_number] => 18/613528 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4569 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19477222 [patent_doc_number] => 20240325264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => COMPOSITIONS COMPRISING BIOACTIVE GLASS AND AMINO ACID [patent_app_type] => utility [patent_app_number] => 18/613904 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19417367 [patent_doc_number] => 20240293490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => CHRYSANTHEMUM ZAWADSKII EXTRACT AND PREPARING METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/593373 [patent_app_country] => US [patent_app_date] => 2024-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18593373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462302 [patent_doc_number] => 20240315971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => MICROSPHERE FORMULATIONS AND METHODS OF PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/592719 [patent_app_country] => US [patent_app_date] => 2024-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18592719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20206188 [patent_doc_number] => 20250275908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => COSMETIC COMPOSITION FOR ACNE CARE [patent_app_type] => utility [patent_app_number] => 18/591930 [patent_app_country] => US [patent_app_date] => 2024-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18591930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20192093 [patent_doc_number] => 20250268803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => SUNSCREEN PREPARATION [patent_app_type] => utility [patent_app_number] => 18/585371 [patent_app_country] => US [patent_app_date] => 2024-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585371 [rel_patent_id] =>[rel_patent_doc_number] =>)